Neurobiology and treatment of attention deficit hyperactivity disorder: A review of the recent data;Le trouble déficitaire de l'attention avec hyperactivité: données récentes des neurosciences et de l'expérience nord-américaine

Neuropsychiatrie de l'Enfance et de l'Adolescence

Volumn 58, Issue 5, 2010, Pages 273-281

  Gonon, F ^a   Guile J M ^b   Cohen, D ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Dopamine; Heritability; Methylphenidate; Psychostimulants

Indexed keywords

DOPAMINE; METHYLPHENIDATE; NORADRENALIN; PSYCHOSTIMULANT AGENT;

ACADEMIC ACHIEVEMENT; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONDUCT DISORDER; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; ENVIRONMENTAL FACTOR; HERITABILITY; HUMAN; NEUROBIOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PRESCRIPTION; PSYCHOSOCIAL CARE; RISK ASSESSMENT; SUBSTANCE ABUSE;

EID: 77955277305     PISSN: 02229617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurenf.2010.02.004     Document Type: Article

References (78)

1. Froehlich T.E., Lanphear B.P., Epstein J.N., Barbaresi W.J., Katusic S.K., Kahn R.S. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007, 161:857-864.
2. Schmitz M.F., Filippone P., Edelman E.M. Social representation of attention deficit/hyperactivity disorder. Cult Psychol 2003, 9:383-406.
3. Bull C., Whelan T. Parental schemata in the management of children with attention deficit-hyperactivity disorder. Qual Health Res 2006, 16:664-678.
4. Cohen D. Vers un modèle développemental d'épigenèse probabiliste du trouble des conduites et des troubles externalisés de l'enfant et de l'adolescent. Neuropsychiatr Enfance Adolesc 2008, 56:237-244.
5. Cohen D. Probabilistic epigenesis: an alternative causal model for conduct disorders in children and adolescents. Neurosci Biobehav Rev 2010;34:119-29.
6. Abou-Abdallah T, Guilé JM, Menusier C, Plaza M, Cohen D. Corrélats cognitifs et relationnels associés aux troubles de l'attention avec/sans hyperactivité. Neuropsichiatr Enfance Adolesc 2009; in press, doi:10.1016/j.neurenf.2009.07.001.
7. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86.
8. Kollins S.H. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). Am J Addict 2007, 16(Suppl. 1):35-42.
9. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008, 47:21-31.
10. Yano M., Steiner H. Methylphenidate and cocaine: the same effects on gene regulation?. Trends Pharmacol Sci 2007, 28:588-596.
11. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008, 456:702-705.
12. Iversen S.D., Iversen L.L. Dopamine: 50 years in perspective. Trends Neurosci 2007, 30:188-193.
13. Swanson J.M., Kinsbourne M., Nigg J., Lanphear B., Stefanatos G.A., Volkow N., et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 2007, 17:39-59.
14. Rapoport J.L., Buchsbaum M.S., Zahn T.P., Weingartner H., Ludlow C., Mikkelsen E.J. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 1978, 199:560-563.
15. Gonon F. The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining. Trends Neurosci 2009, 32(1):2-8.
16. Volkow N.D., Wang G.J., Newcorn J., Fowler J.S., Telang F., Solanto M.V., et al. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007, 34:1182-1190.
17. Overtoom C.C., Verbaten M.N., Kemner C., Kenemans J.L., van Engeland H., Buitelaar J.K., et al. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behav Brain Res 2003, 145:7-15.
18. Pliszka S.R. The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1385-1390.
19. Javoy-Agid F., Scatton B., Ruberg M., L'Heureux R., Cervera P., Raisman R., et al. Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex. Neuroscience 1989, 29:251-259.
20. Moron J.A., Brockington A., Wise R.A., Rocha B.A., Hope B.T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 2002, 22:389-395.
21. Dickstein S.G., Bannon K., Castellanos F.X., Milham M.P. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 2006, 47:1051-1062.
22. Smith A.K., Mick E., Faraone S.V. Advances in genetic studies of attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2009, 11:143-148.
23. Faraone S.V., Doyle A.E., Lasky-Su J., Sklar P.B., D'Angelo E., Gonzalez-Heydrich J., et al. Linkage analysis of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1387-1391.
24. Hyman S.E. A glimmer of light for neuropsychiatric disorders. Nature 2008, 455:890-893.
25. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323.
26. Shaw P., Gornick M., Lerch J., Addington A., Seal J., Greenstein D., et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007, 64:921-931.
27. Shaw P., Eckstrand K., Sharp W., Blumenthal J., Lerch J.P., Greenstein D., et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 2007, 104:19649-19654.
28. Lenroot R.K., Gogtay N., Greenstein D.K., Wells E.M., Wallace G.L., Clasen L.S., et al. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 2007, 36:1065-1073.
29. Heiser P., Heinzel-Gutenbrunner M., Frey J., Smidt J., Grabarkiewicz J., Friedel S., et al. Twin study on heritability of activity, attention, and impulsivity as assessed by objective measures. J Atten Disord 2006, 9:575-581.
30. Hay D.A., Bennett K.S., Levy F., Sergeant J., Swanson J. A twin study of attention-deficit/hyperactivity disorder dimensions rated by the strengths and weaknesses of ADHD-symptoms and normal-behavior (SWAN) scale. Biol Psychiatry 2007, 61:700-705.
31. Polderman T.J., Derks E.M., Hudziak J.J., Verhulst F.C., Posthuma D., Boomsma D.I. Across the continuum of attention skills: a twin study of the SWAN ADHD rating scale. J Child Psychol Psychiatry 2007, 48:1080-1087.
32. Banerjee T.D., Middleton F., Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007, 96:1269-1274.
33. Burgner D., Jamieson S.E., Blackwell J.M. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?. Lancet Infect Dis 2006, 6:653-663.
34. Taylor E. Hyperkinetic disorders. A clinician handbook of child and adolescent psychiatry 2006, 489-521. Cambridge University Press, Cambridge. C. Gillberg, R. Harrington, H.C. Steinhausen (Eds.).
35. Denenberg V.H., Rosenberg K.M. Nongenetic transmission of information. Nature 1967, 216:549-550.
36. Liu D., Diorio J., Day J.C., Francis D.D., Meaney M.J. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci 2000, 3:799-806.
37. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7:847-854.
38. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
39. Borrelli E., Nestler E.J., Allis C.D., Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron 2008, 60:961-974.
40. Biederman J., Faraone S.V., Monuteaux M.C. Differential effect of environmental adversity by gender: Rutter's index of adversity in a group of boys and girls with and without ADHD. Am J Psychiatry 2002, 159:1556-1562.
41. Linnet K.M., Wisborg K., Obel C., Secher N.J., Thomsen P.H., Agerbo E., et al. Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics 2005, 116:462-467.
42. Linnet K.M., Wisborg K., Agerbo E., Secher N.J., Thomsen P.H., Henriksen T.B. Gestational age, birth weight, and the risk of hyperkinetic disorder. Arch Dis Child 2006, 91:655-660.
43. Schneider H., Eisenberg D. Who receives a diagnosis of attention-deficit/hyperactivity disorder in the United States elementary school population?. Pediatrics 2006, 117:e601-e609.
44. Christakis D.A., Zimmerman F.J., DiGiuseppe D.L., McCarty C.A. Early television exposure and subsequent attentional problems in children. Pediatrics 2004, 113:708-713.
45. Barbaresi W.J., Katusic S.K., Colligan R.C., Weaver A.L., Jacobsen S.J. Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr 2007, 28:265-273.
46. Panksepp J. Can play diminish ADHD and facilitate the construction of the social brain?. J Can Acad Child Adolesc Psychiatry 2007, 16:57-66.
47. Fabiano G.A. Father participation in behavioral parent training for ADHD: review and recommendations for increasing inclusion and engagement. J Fam Psychol 2007, 21:683-693.
48. Hurt E.A., Hoza B., Pelham W.E. Parenting, family loneliness, and peer functioning in boys with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol 2007, 35:543-555.
49. DeKlyen M., Speltz M.L., Greenberg M.T. Fathering and early onset conduct problems: positive and negative parenting, father-son attachment, and the marital context. Clin Child Fam Psychol Rev 1998, 1:3-21.
50. NICHD. Fathers' and mothers' parenting behavior and beliefs as predictors of children's social adjustment in the transition to school. J Fam Psychol 2004;18:628-38.
51. Fabiano G.A., Chacko A., Pelham W.E., Robb J., Walker K.S., Wymbs F., et al. A comparison of behavioral parent training programs for fathers of children with attention-deficit/hyperactivity disorder. Behav Ther 2009, 40:190-204.
52. Root R.W., Resnick R.J. An update on the diagnosis and treatment of attention-deficit/hyperactivity disorder in children. Prof Psychol Res Pract 2003, 34:34-41.
53. The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762-9.
54. Barkley R.A. International consensus statement on ADHD. Clin Child Fam Psychol Rev 2002, 5:89-111.
55. Barkley R.A., Fischer M., Smallish L., Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004, 45:195-211.
56. Molina B.S., Flory K., Hinshaw S.P., Greiner A.R., Arnold L.E., Swanson J.M., et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 2007, 46:1028-1040.
57. Flory K., Lynam D.R. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?. Clin Child Fam Psychol Rev 2003, 6:1-16.
58. Lahey B.B., Loeber R., Burke J.D., Applegate B. Predicting future antisocial personality disorder in males from a clinical assessment in childhood. J Consult Clin Psychol 2005, 73:389-399.
59. August G.J., Winters K.C., Realmuto G.M., Fahnhorst T., Botzet A., Lee S. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry 2006, 45:824-832.
60. Molina B.S., Hinshaw S.P., Swanson J.M., Arnold L.E., Vitiello B., Jensen P.S., et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009, 48:484-500.
61. Biederman J., Wilens T., Mick E., Spencer T., Faraone S.V. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999, 104:e20.
62. Biederman J., Monuteaux M.C., Spencer T., Wilens T.E., Macpherson H.A., Faraone S.V. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study. Am J Psychiatry 2008, 165:597-603.
63. Loe I.M., Feldman H.M. Academic and educational outcomes of children with ADHD. J Pediatr Psychol 2007, 32:643-654.
64. Barbaresi W.J., Katusic S.K., Colligan R.C., Weaver A.L., Jacobsen S.J. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr 2007, 28:274-287.
65. Food and drug administration. Promotional claims false and misleading; 2008. Available from: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2008.
66. Rushton J.L., Fant K.E., Clark S.J. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics 2004, 114:e23-e28.
67. Rosenthal R., Jacobson L. Pygmalion à l'école: l'attente du maître et le développement intellectuel des élèves 1971, Castermann, Paris.
68. Lara C., Fayyad J., de Graaf R., Kessler R.C., Aguilar-Gaxiola S., Angermeyer M., et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey initiative. Biol Psychiatry 2009, 65:46-54.
69. Marcelli D, Cohen D. Enfance et psychopathologie. 8e ed. Paris: Masson; 2009.
70. Armstrong M.B., Nettleton S.K. Attention deficit hyperactivity disorder and preschool children. Semin Speech Lang 2004, 25:225-232.
71. Pelham W.E., Fabiano G.A. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child. Adolesc Psychol 2008, 37:184-214.
72. Kaiser N.M., Hoza B., Hurt E.A. Multimodal treatment for childhood attention-deficit/hyperactivity disorder. Expert Rev Neurother 2008, 8:1573-1583.
73. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults; 2008. Available from: http://www.nice.org.uk/CG072.
74. Gould M.S., Walsh B.T., Munfakh J.L., Kleinman M., Duan N., Olfson M., et al. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009, 166:992-1001.
75. Graindorge C. Hyperactivité de l'enfant: une approche psychopathologique. Ann Med Psychol 2006, 164:607-612.
76. Kendell R., Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003, 160:4-12.
77. Hyman S.E. Can neuroscience be integrated into the DSM-V?. Nat Rev Neurosci 2007, 8:725-732.
78. Moller H.J. Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach. World J Biol Psychiatry 2009, 2:1-16.